Nyxoah (NYXH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.402x

Based on the latest financial reports, Nyxoah (NYXH) has a cash flow conversion efficiency ratio of -0.402x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.48 Million ≈ $-23.95 Million USD) by net assets (€50.95 Million ≈ $59.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nyxoah - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nyxoah's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Nyxoah debt and liabilities for a breakdown of total debt and financial obligations.

Nyxoah Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nyxoah ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Woorim Machinery Co. Ltd
KQ:101170
-0.035x
Easy Field
TWO:6425
-0.057x
Business Online PCL
BK:BOL
0.012x
Pyrum Innovations AG
OL:PYRUM
-0.116x
Bellevue Group AG
SW:BBN
0.150x
Alpha Cognition Inc
NASDAQ:ACOG
-0.158x
Aesler Grup Internasional Tbk Pt
JK:RONY
-1.290x
HYUNDAI FEED Inc
KQ:016790
0.015x

Annual Cash Flow Conversion Efficiency for Nyxoah (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nyxoah from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Nyxoah.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €113.25 Million
≈ $132.41 Million
€-49.23 Million
≈ $-57.55 Million
-0.435x +4.85%
2023-12-31 €98.02 Million
≈ $114.60 Million
€-44.78 Million
≈ $-52.35 Million
-0.457x -91.15%
2022-12-31 €120.32 Million
≈ $140.67 Million
€-28.76 Million
≈ $-33.62 Million
-0.239x -40.19%
2021-12-31 €148.62 Million
≈ $173.75 Million
€-25.34 Million
≈ $-29.62 Million
-0.170x -141.38%
2020-12-31 €97.19 Million
≈ $113.63 Million
€-6.86 Million
≈ $-8.02 Million
-0.071x +95.58%
2019-12-31 €3.71 Million
≈ $4.34 Million
€-5.93 Million
≈ $-6.94 Million
-1.598x -105.20%
2018-12-31 €10.45 Million
≈ $12.22 Million
€-8.14 Million
≈ $-9.52 Million
-0.779x +57.47%
2017-12-31 €4.53 Million
≈ $5.29 Million
€-8.29 Million
≈ $-9.69 Million
-1.831x --

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies
Market Cap
$127.27 Million
€108.86 Million EUR
Market Cap Rank
#18262 Global
#80 in Belgium
Share Price
€2.53
Change (1 day)
+1.20%
52-Week Range
€2.40 - €7.70
All Time High
€29.90
About

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more